Fot. Getty Images/iStockphoto
A study by South African scientists has shown that a booster dose of Johnson & Johnson's COVID-19 vaccines is also highly effective against the new variant of the coronavirus Omikron. This is another formulation (after the AstraZeneca, Pfizer and Moderna vaccines) that has had such results.
A single-dose booster dose of Johnson & Johnson's COVID-19 vaccine was 84% effective in preventing hospitalization in South African health workers who became infected as a result of the spread of the Omikron variant, the country's health service said.
The South African study looked at 69,092 health car...
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in